drugset / Trial / NCT00290173

Ritodrine in Oral Maintenance of Tocolysis After Active Preterm Labor

NCT00290173 ↗

RandomizedSingle-groupOpen-labelTreatment

Summary

This is a trial comparing the efficacy of oral ritodrine in the form of sustained release capsules for the maintenance of uterine quiescence after successfully treated episode of threatened preterm labor.

Timeline

Start
—
Primary completion
—
Completion
2005-08

Outcome

Missed primary endpoint

paper recurrent episodes of threatened preterm labor requiring another course of intravenous treatment between the study (8/62) and control (6/58) group of women (P=0.879). PMID 16489694 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ritodrine Small molecule 80 mg Oral

Indications